Bill Poulos
Bill Poulos has been analyzing the markets and investing since the early 70s. Investing used to be only a much loved hobby of his but in 2001, after retiring from his day job as an automotive executive at GM, he cofounded Profits Run, Inc. He and his son (Greg) now help individuals become smarter investors while properly managing risk.
Is the Market Going to Crash Again? It Could If Congress...
Stocks are trading flat this morning as investors bear witness to continued gridlock in Washington. D.C. lawmakers remain split on a coronavirus relief bill,...
Don’t Get Too Excited About the July Jobs Report
Trump was right.
The July jobs report – released this morning – showed a “yuge” payroll gain just like he said it would. 1.763 million...
The Turkish Lira Is Forming Another “Black Swan” Event
Stocks are trading flat this morning as investors weigh offsetting economic data. Better-than-expected employment numbers were released today, revealing a weekly jobless rise of...
How the TikTok Deal Could Impact Tech Stocks
Stocks are edging higher today as investors await the new coronavirus stimulus package. Lawmakers in Washington feel confident that they’re making progress, but so...
Big Tech Earnings Could “Doom” Stock Market
The second-quarter GDP numbers are in and they’re better than expected.
That does not mean, however, that investors are feeling good about them.
According to the...
Another Bitcoin Rally Is Coming
Stocks are slightly down this morning as Congress squabbles over coronavirus relief packages. A slew of poor quarterly earnings are keeping the bulls at...
FAANG Is Crumbling, Signaling Dark Days Ahead
The quarterly results are in from two of the market’s top stocks – Microsoft (NASDAQ: MSFT) and Tesla (NASDAQ: TSLA) – revealing big-time earnings...
Gold Could Keep Rising, Even with a Vaccine
The Dow’s down. The S&P’s flat.
And the Nasdaq Composite is soaring.
It’s a new week, and as of this morning, the market’s already off to...
New Study Finds Moderna’s Vaccine Is Only a “Short-Term” Covid-19 Solution
Stocks are falling this morning, driven lower by worse-than-expected weekly jobless claims and a post-“vaccine blitz” hangover.
On Tuesday afternoon, biotech firm Moderna (NASDAQ: MRNA)...
Why JPMorgan Chase’s Earnings “Beat” Was Actually a “Miss”
Another day, another uneven trading session.
That’s been the trend over the last few weeks.
And with investors unsure of where the market is truly headed,...